Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses
about
Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase.The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1.Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment.Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha.Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome.Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicateConserved herpesvirus protein kinases.Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.The co-chaperone BAG3 regulates Herpes Simplex Virus replication.Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavirTegument proteins of human cytomegalovirusFunction of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.Viral serine/threonine protein kinasesTinkering with translation: protein synthesis in virus-infected cells.The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclinsProteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta.The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionMaribavir inhibits epstein-barr virus transcription in addition to viral DNA replicationCharacterization of the human herpesvirus 6 U69 gene product and identification of its nuclear localization signal.The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase DomainHuman cytomegalovirus UL97 phosphorylates the viral nuclear egress complexMapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.
P2860
Q30367232-05002043-B4A4-460E-8E3A-27868F7216F0Q33794196-98E9749A-8B7A-4B2E-B932-92A18F70DC13Q33801066-B39A1C5B-AD71-4B47-9DD3-C28D5630313EQ33854952-E6A247B1-35EF-46ED-94DC-C0B0B9C74AF0Q33995747-936D8614-FD5D-4300-B1CA-8415D3BE5CA9Q34108700-C5C8CE3A-1BA4-49EC-8462-74993D6D241DQ34109911-8C50ABFE-B8BD-4814-9A67-2682317F9EB1Q34302174-8B36EBFA-83F0-4D14-98A1-111647E005BAQ34742654-AE11859D-3C93-480C-BF18-611102DD116DQ34952284-2E28FDC9-9BC4-4B68-BDD1-A006B7BA5274Q35667107-FCC580D1-F8A6-4362-B9F6-741C5C3F3A7EQ35857562-2724B7B4-A6B2-4B0D-8ED2-DF6643AB4C46Q35910572-F190B320-433C-4C4E-8576-6A7E5B2405F1Q36212341-50667FD3-5BA1-42D9-BA97-89EC921D3D05Q36418247-51C189F1-917D-4366-9870-77DE7DA5F0F2Q36491044-5A89DA12-35F9-4C04-A6EC-4BD33D53138DQ36978826-09796059-638A-4CB9-A5D7-404AFB25B024Q37002556-2C3FC9A7-07A4-4F5A-A3B3-B6E974EB2900Q37016389-FC008C0A-9CF1-4DFF-9F2D-B6745AF17357Q37085793-7C329104-1EF8-4CB5-B846-5E551A7897A4Q37183914-48773BD4-64A5-432E-ADB7-9FE5239639AFQ37478310-64254940-FB7D-4DBD-98DE-1B7EF3175C41Q37810382-A8485A68-319E-427B-90E4-49F52A707626Q38064834-131CB2D8-4914-412D-92B4-827828D65ED3Q38534801-8539294F-3359-44B8-B119-B8AD291F52BBQ39467030-760081E1-6664-4819-A950-163914BFA932Q39585516-30546226-B45C-41D8-97B0-F42F5A3B23FAQ39700313-8D5851AF-77A0-4D4C-8D27-FE1F3A22B333Q39735571-6C5103C5-B808-4245-864A-EE1AAA180783Q39798789-3C049F36-20C3-432B-8B3C-DC38A613D105Q40051825-121C11F9-A29B-4E6D-97EF-19BE8E09D1E8Q41485874-95FCD0CB-AFC7-46E8-9F5A-9C2620E6916CQ41691057-B2608835-7E62-4651-ADFC-0E97B850D920Q43002049-6E3A7769-00BB-4E60-8F7B-FF16C01A0A51
P2860
Cellular elongation factor 1delta is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@ast
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@en
type
label
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@ast
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@en
prefLabel
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@ast
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@en
P2093
P2860
P1433
P1476
Cellular elongation factor 1de ...... , beta-, or gammaherpesviruses
@en
P2093
P2860
P304
P577
1999-05-01T00:00:00Z